AbramsDCombesABrodieD. Extracorporeal membrane oxygenation in cardiopulmonary disease in adults. J Am Coll Cardiol2014; 63: 2769–2778.
2.
WangLYangFWangX, et al. Predicting mortality in patients undergoing VA-ECMO after coronary artery bypass grafting: the REMEMBER score. Crit Care2019; 23: 11.
3.
MillarJEFanningJPMcDonaldCI, et al. The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology. Crit Care2016; 20: 387.
4.
WangLShaoJFanE, et al. Disseminated intravascular coagulation score is related to short-term mortality in patients undergoing venoarterial extracorporeal mem-brane oxygenation after cardiac surgery. ASAIO J. Epub ahead of print 11 January 2021. DOI: 10.1097/MAT.0000000000001333.
5.
AtallahSLieblMFitousisK, et al. Evaluation of the activated clotting time and activated partial thromboplastin time for the monitoring of heparin in adult extracorporeal membrane oxygenation patients. Perfusion2014; 29: 456–461.
6.
BembeaMMAnnichGRycusP, et al. Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: an international survey. Pediatr Crit Care Med2013; 14: e77–e84.
7.
DelmasCJacqueminAVardon-BounesF, et al. Anticoagulation monitoring under ECMO support: a comparative study between the activated coagulation time and the anti-xa activity assay. J Intensive Care Med2020; 35: 679–686.
8.
WillemsARoeleveldPPLabarinasS, et al. Anti-Xa versus time-guided anticoagulation strategies in extracorporeal membrane oxygenation: a systematic review and meta-analysis. Perfusion 2021; 36: 501–512.
